Contraception
Conditions
Keywords
Oral contraceptive
Brief summary
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
Interventions
Patients in daily life clinical practice treatment receiving Yasmin according to indication on the label.
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Women who need oral contraceptive
Exclusion criteria
* Patient who belongs to contraindication listed on the product label.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety and efficacy in real practice | After 6 cycle of treatment |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Event / Serious AE collection | At point of the occurence |
| Patient's compliance | After 6 cycle of treatment or at the point of withdrawan |
| Demography | At initial visit |
| Medical History | At initial visit |
| Administration period of Yasmin | After 6 cycle of treatment or at the point of withdrawan |
Countries
South Korea
Outcome results
None listed